About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies

STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies

NCT02788825·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Karolinska Institutet

Age

45–75

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Men age 45-75 years referred to any of the participating urological centers for prostate biopsies

You may not be if

A prior diagnosis of prostate cancer (ICD-9 C61)
Severe illnesses such as metastatic cancers, severe cardio-vascular disease or dementia
Contraindications for magnetic resonance imaging (MRI) eg pacemaker, magnetic cerebral clips, cochlear implants or severe claustrophobia.

The record

StatusCompleted

PhaseNo phase

Taking part687

StartedApr 2016

UpdatedAug 22, 2017

Conditions

Prostate Cancer

Where2

Aleris Oslo
Oslo, Norway
Karolinska Universitetssjukhuset, Solna
Stockholm, Sweden